Dutasteride for the treatment of prostate-related conditions

@article{Slater2012DutasterideFT,
  title={Dutasteride for the treatment of prostate-related conditions},
  author={S. Slater and C. Dumas and G. Bubley},
  journal={Expert Opinion on Drug Safety},
  year={2012},
  volume={11},
  pages={325 - 330}
}
  • S. Slater, C. Dumas, G. Bubley
  • Published 2012
  • Medicine
  • Expert Opinion on Drug Safety
    • Introduction: A variety of pharmaceuticals have been developed directed at mitigating the symptoms associated with benign prostatic hypertrophy (BPH) and have also been evaluated for their potential role in prevention and treatment of prostate cancer. One such agent is dutasteride, a non-selective inhibitor of 5α-reductase, an enzyme responsible for conversion of testosterone to a more potent androgen dihydrotestosterone (DHT). Areas covered: This review will cover the safety profile of… CONTINUE READING
    View on Taylor & Francis
    ncbi.nlm.nih.gov
    9 Citations
    Highly Influential Citations
    1
    Background Citations
    5
    Methods Citations
    1

    Paper Mentions

    Interventional Clinical Trial
    Impact of the Combined Treatment of Liposomed Polyphenols With Dutasteride on the ALS Patients
    Amyotrophic lateral sclerosis (ALS) is a disease of an inflammatory nature, which causes progressive muscle weakness associated with cognitive and behavioural disorders… Expand
    ConditionsAmyotrophic Lateral Sclerosis
    InterventionDietary Supplement, Drug, Other
    Fundación Universidad Católica de Valencia San Vicente Mártir
    January 2021 - August 2021
    9 Citations
    Citation Type

    Citation Type

    Hormonal manipulation of benign prostatic hyperplasia
    • 18
    Recent discoveries and developments of androgen receptor based therapy for prostate cancer
    • 10
    • PDF
    Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells
    • 18
    • PDF
    Growth hormone‐releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan‐induced chronic prostatitis
    • 14
    • Highly Influenced
    Glucocorticoid metabolism in rheumatoid arthritis
    • 8
    Anabolic potential of bone mineral in human periosteal fibroblasts using steroid markers of healing
    • 1
    Fluorinated steroids and their derivatives
    • 8
    Re: Antagonists of Growth Hormone-Releasing Hormone Inhibit Proliferation Induced by Inflammation in Prostatic Epithelial Cells.
    • A. Atala
    • Medicine
    • The Journal of urology
    • 2017
    Preclinical therapy of benign prostatic hyperplasia with neuropeptide hormone antagonists
    • 3

    References

    SHOWING 1-10 OF 29 REFERENCES
    The influence of finasteride on the development of prostate cancer.
    • 2,463
    • PDF
    Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.
    • 223
    • Highly Influential
    The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
    • 546
    • Highly Influential
    Effect of dutasteride on the risk of prostate cancer.
    • 939
    • Highly Influential
    • PDF
    Overview of pivotal studies for prostate cancer risk reduction, past and present.
    • 19
    • Highly Influential
    The effect of finasteride in men with benign prostatic hyperplasia.
    • P. Walsh
    • Medicine
    • The Journal of urology
    • 1993
    • 876
    Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer
    • 73
    • PDF
    Effect of dutasteride on prostate cancer progression and cancer diagnosis on rebiopsy in the REDEEM active surveillance study.
    • 11
    Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.
    • 635
    Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.
    • 154